Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications

Epidemiologic studies strongly support that triple-negative breast cancers (TNBCs) may be distinct entities as compared with estrogen receptor (ER)+ tumors, suggesting that the etiologic factors, clinical characteristics, and therapeutic possibilities may vary by molecular subtypes. Many investigati...

Descripción completa

Detalles Bibliográficos
Autor principal: Suba, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905095/
https://www.ncbi.nlm.nih.gov/pubmed/24482576
http://dx.doi.org/10.2147/OTT.S52600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905095/
https://www.ncbi.nlm.nih.gov/pubmed/24482576
http://dx.doi.org/10.2147/OTT.S52600

Ejemplares similares